Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Opsens Inc T.OPS

OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR... see more

TSX:OPS - Post Discussion

Opsens Inc > Comparison
View:
Post by retiredcf on Nov 06, 2022 7:55am

Comparison

What are your thoughts on Perimeter Medical Imaging AI versus Opsens at this time? Which do you prefer?

PINK has marginal revenue, losses, negative cash flow and not much cash. It has some strong shareholders, but with the stock down 66% this year and market cap of only $88M, it is tough to make a case for it in an uncertain market. We would expect tax loss selling and it will likely need capital soon. OPS is much larger, has a decent revenue base, much more cash and only marginally negative cash flow. Insiders own 5% and it has held up much better in the market decline. There is decent potential, but also plenty of risk. But of the two, we would far prefer OPS over PINK. (5iResearch)

Comment by WhiteknightA on Nov 06, 2022 7:06pm
Both companies are excellent choices, and both companies will succeed. Pink is such a new company in its infancy stage right now. You can forget all the numbers related to their financials for the most part. They had a massive investment put up almost a year ago by a very prominent individual, so that speaks volumes. The company has incredible break threw technology with its AI software. The ...more  
Comment by WhiteknightA on Nov 06, 2022 7:12pm
Pink has enough capital to get them through their trial stage. That cash comes from a big investment social capital. The company will not go under at all. Their technology is far to valuable. They won't start producing revenue until they get fda approved. Then they can start selling their technology and thus get listed on the nyse/Nasdaq. I strongly feel 3 years maybe 5. The stock will be 10!& ...more  
Comment by GoldenArm on Nov 11, 2022 3:42pm
100% agree. A big bank has a lot invested in them.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities